Today, Fortimedix Surgical, a minimally invasive surgical medical device company, announced the completion of a €11 million (approximately $12.2 million) Series A round of financing, led by Chemelot Ventures, MKB Leningenfonds, and Rijksdienst voor Ondernemend Nederland.

Fortimedix Surgical, a rapidly growing medical device company in recent years, was founded in 1999 and is headquartered in Limburg, the Netherlands, with a subsidiary in San Diego, California, USA, dedicated to changing minimally invasive surgery with new devices in single-hole technology. At present, they have a large number of internal support manufacturing facilities and master key manufacturing technologies such as laser cutting, electropolishing and heat treatment.

The newly injected funds will be used to promote the FMX314 in the US and Europe. The FMX314 is the world's first single-hole laparoscopic minimally invasive surgical solution using standard 15mm trocars. The surgeon can use the comfortable and safe single-hole method according to the human body. Engineering performs surgery. Reducing the number of incisions and minimizing abdominal wall trauma is the key to laparoscopic surgery. FMX314 therapy has fewer complications, less postoperative pain, faster recovery, and lesser skin trauma.

FMX314 surgical tool

Disposable Use Puncture Guider

Disposable Use Puncture Guider,All Laparoscopic Instruments,Keyhole Surgery Instruments,Surgical Laparoscopic Machine

Changzhou Weipu Medical Devices Co., Ltd. , https://www.cnweipumedical.com